Is Discontinuation of Oral Anticoagulation Therapy Necessary for Orthobiologic Interventions?
Main Article Content
Keywords
Anticoagulation, blood thinner, bleeding, injection
Abstract
N/A viewpoint submission
References
1. IBM Truven Health Analytics, 12 months ending December 31, 2018 for Commercial, Medicare and Medicaid patients (October 24, 2019). https://www.ibm.com/watson-health/about/truven-health-analytics
2. Kim DC, Ku SK, Bae JS. Anticoagulant activities of curcumin and its derivative. BMB Rep. 2012;45(4): 221–6. https://doi.org/10.5483/bmbrep.2012.45.4.221
3. Davidson JC, Rahim S, Hanks SE, et al. Society of interventional radiology consensus guidelines for the periprocedural management of thrombotic and bleeding risk in patients undergoing percutaneous image-guided interventions—Part I: Review of anticoagulation agents and clinical considerations: Endorsed by the Canadian Association for Interventional Radiology and the Cardiovascular and Interventional Radiological Society of Europe. J Vasc Interv Radiol. 2019;30(8):1155–67. https://doi.org/10.1016/j.jvir.2019.04.016
4. Macle L, Cairns J, Leblanc K, et al. Focused update of the Canadian Cardiovascular Society guidelines for the management of atrial fibrillation. J Cardiol. 2016;32:1170–85. https://doi.org/10.1016/j.cjca.2016.07.591
5. Narouze S, Benzon HT, Provenzano D, et al. Interventional spine and pain procedures in patients on antiplatelet and anticoagulant medications (Second Edition): Guidelines from the American Society of Regional Anesthesia and Pain Medicine, the European Society of Regional Anaesthesia and Pain Therapy, the American Academy of Pain Medicine, the International Neuromodulation Society, the North American Neuromodulation Society, and the World Institute of Pain. Reg Anesth Pain Med. 2018;43(3):225–62. https://doi.org/10.1097/AAP.0000000000000700
6. Khandelwal A. Bleeding risk assessment for bedside and interventional radiology–guided procedures: Consensus guidelines and beyond. Ontario Regional Blood Coordinating Network [Internet]. 2020 Jun [cited 2020 Sep 1]. Available from: https://transfusionontario.org/en/june-2020
7. Somerville P, Seifert PJ, Destounis SV, et al. Anticoagulation and bleeding risk after core needle biopsy. AJR Am J Roentgenol. 2008;191(4):1194–7. https://doi.org/10.2214/AJR.07.3537
2. Kim DC, Ku SK, Bae JS. Anticoagulant activities of curcumin and its derivative. BMB Rep. 2012;45(4): 221–6. https://doi.org/10.5483/bmbrep.2012.45.4.221
3. Davidson JC, Rahim S, Hanks SE, et al. Society of interventional radiology consensus guidelines for the periprocedural management of thrombotic and bleeding risk in patients undergoing percutaneous image-guided interventions—Part I: Review of anticoagulation agents and clinical considerations: Endorsed by the Canadian Association for Interventional Radiology and the Cardiovascular and Interventional Radiological Society of Europe. J Vasc Interv Radiol. 2019;30(8):1155–67. https://doi.org/10.1016/j.jvir.2019.04.016
4. Macle L, Cairns J, Leblanc K, et al. Focused update of the Canadian Cardiovascular Society guidelines for the management of atrial fibrillation. J Cardiol. 2016;32:1170–85. https://doi.org/10.1016/j.cjca.2016.07.591
5. Narouze S, Benzon HT, Provenzano D, et al. Interventional spine and pain procedures in patients on antiplatelet and anticoagulant medications (Second Edition): Guidelines from the American Society of Regional Anesthesia and Pain Medicine, the European Society of Regional Anaesthesia and Pain Therapy, the American Academy of Pain Medicine, the International Neuromodulation Society, the North American Neuromodulation Society, and the World Institute of Pain. Reg Anesth Pain Med. 2018;43(3):225–62. https://doi.org/10.1097/AAP.0000000000000700
6. Khandelwal A. Bleeding risk assessment for bedside and interventional radiology–guided procedures: Consensus guidelines and beyond. Ontario Regional Blood Coordinating Network [Internet]. 2020 Jun [cited 2020 Sep 1]. Available from: https://transfusionontario.org/en/june-2020
7. Somerville P, Seifert PJ, Destounis SV, et al. Anticoagulation and bleeding risk after core needle biopsy. AJR Am J Roentgenol. 2008;191(4):1194–7. https://doi.org/10.2214/AJR.07.3537
Article Sidebar
Published
Jun 20, 2022
Article Details
How to Cite
Purita, J., Fabio Santos Duarte Lana, J., & Kolber, M. (2022). Is Discontinuation of Oral Anticoagulation Therapy Necessary for Orthobiologic Interventions?. Biologic Orthopedics Journal, 4(SP1), e1-e3. https://doi.org/10.22374/boj.v4iSP1.44
Section
Viewpoint
This work is licensed under a Creative Commons Attribution 4.0 International License.
Author Biographies
Joseph Purita MD, Institute of Regenerative Medicine, Boca Raton, FL, USA
Institute of Regenerative Medicine, Boca Raton, FL, USA
José Fabio Santos Duarte Lana, MD , Cidade Nova, Indaiatuba, São Paulo, Brazil
Cidade Nova, Indaiatuba, São Paulo, Brazil
Morey Kolber, Nova Southeastern University, Fort Lauderdale, FL, USA
Nova Southeastern University, Fort Lauderdale, FL, USA